Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan C Moss

Showing results (91-100 of 134) with videos related to

Pageof 14
Sort By:
Inflammatory Bowel Diseases|September 29, 2011
Screening for tuberculosis and hepatitis B prior to the initiation of anti-tumor necrosis therapyByron P Vaughn, Glen A Doherty, Shiva Gautam, et al.
Inflammatory Bowel Diseases|April 1, 2014
Vitamin D levels in adults with Crohn's disease are responsive to disease activity and treatmentMaggie Ham, Maria S Longhi, Conor Lahiff, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 27, 2019
Successful treatment of fulminant Clostridioides difficile infection with emergent fecal microbiota transplantation in a patient with acute myeloid leukemia and prolonged, severe neutropeniaMatthew S L Lee, Bharat Ramakrishna, Alan C Moss, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2006
Corticotropin-releasing hormone receptor 2-deficient mice have reduced intestinal inflammatory responsesEfi Kokkotou, Daniel Torres, Alan C Moss, et al.
Cytokine|January 12, 2018
Higher serum vitamin D levels are associated with protective serum cytokine profiles in patients with ulcerative colitisJohn Gubatan, Shuji Mitsuhashi, Maria Serena Longhi, et al.
The American Journal of Gastroenterology|January 9, 2013
A random urine test can identify patients at risk of mesalamine non-adherence: a prospective studyAnne E Gifford, Anders H Berg, Conor Lahiff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2023
Accelerating the Evolution of Immune-Related Enterocolitis ManagementDavid M Faleck, Michael Dougan, Monique Tello, et al.
Journal of Clinical Gastroenterology|August 4, 2010
Cyclosporine is safe and effective in patients with severe ulcerative colitisAdam S Cheifetz, Joshua Stern, Sagar Garud, et al.
Journal of Crohn'S & Colitis|December 3, 2010
Impact of a patient-support program on mesalamine adherence in patients with ulcerative colitis--a prospective studyAlan C Moss, Nabeel Chaudhary, Melissa Tukey, et al.
Inflammatory Bowel Diseases|June 8, 2011
Abdominal phlegmons in Crohn's disease: outcomes following antitumor necrosis factor therapyGarret Cullen, Byron Vaughn, Awais Ahmed, et al.
Pageof 14

Showing results (91-100 of 134) with videos related to

Sort By:
Pageof 14
Inflammatory Bowel Diseases|September 29, 2011
Screening for tuberculosis and hepatitis B prior to the initiation of anti-tumor necrosis therapyByron P Vaughn, Glen A Doherty, Shiva Gautam, et al.
Inflammatory Bowel Diseases|April 1, 2014
Vitamin D levels in adults with Crohn's disease are responsive to disease activity and treatmentMaggie Ham, Maria S Longhi, Conor Lahiff, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 27, 2019
Successful treatment of fulminant Clostridioides difficile infection with emergent fecal microbiota transplantation in a patient with acute myeloid leukemia and prolonged, severe neutropeniaMatthew S L Lee, Bharat Ramakrishna, Alan C Moss, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2006
Corticotropin-releasing hormone receptor 2-deficient mice have reduced intestinal inflammatory responsesEfi Kokkotou, Daniel Torres, Alan C Moss, et al.
Cytokine|January 12, 2018
Higher serum vitamin D levels are associated with protective serum cytokine profiles in patients with ulcerative colitisJohn Gubatan, Shuji Mitsuhashi, Maria Serena Longhi, et al.
The American Journal of Gastroenterology|January 9, 2013
A random urine test can identify patients at risk of mesalamine non-adherence: a prospective studyAnne E Gifford, Anders H Berg, Conor Lahiff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2023
Accelerating the Evolution of Immune-Related Enterocolitis ManagementDavid M Faleck, Michael Dougan, Monique Tello, et al.
Journal of Clinical Gastroenterology|August 4, 2010
Cyclosporine is safe and effective in patients with severe ulcerative colitisAdam S Cheifetz, Joshua Stern, Sagar Garud, et al.
Journal of Crohn'S & Colitis|December 3, 2010
Impact of a patient-support program on mesalamine adherence in patients with ulcerative colitis--a prospective studyAlan C Moss, Nabeel Chaudhary, Melissa Tukey, et al.
Inflammatory Bowel Diseases|June 8, 2011
Abdominal phlegmons in Crohn's disease: outcomes following antitumor necrosis factor therapyGarret Cullen, Byron Vaughn, Awais Ahmed, et al.
Pageof 14